• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide (CAS No. 618092-44-7): A Comprehensive Overview

5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide (CAS No. 618092-44-7) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various biological applications, particularly in the development of novel therapeutic agents.

The molecular structure of 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide consists of a pyrazole ring substituted with a methyl group at the 5-position and a p-tolyl group at the 1-position. The carbohydrazide moiety attached to the 4-position of the pyrazole ring imparts additional functional groups that can interact with biological targets, making this compound a valuable scaffold for drug design.

Recent studies have highlighted the diverse biological activities of 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide. One notable area of research is its potential as an anti-inflammatory agent. In vitro and in vivo studies have demonstrated that this compound can effectively inhibit the production of pro-inflammatory cytokines, such as TNF-α and IL-6, which are key mediators of inflammation. This property makes it a promising candidate for the treatment of inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease.

Furthermore, 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide has shown significant antitumor activity. Research conducted on various cancer cell lines has revealed that this compound can induce apoptosis and cell cycle arrest, thereby inhibiting tumor growth. The mechanism of action appears to involve the modulation of signaling pathways associated with cell survival and proliferation, such as the PI3K/Akt and MAPK pathways. These findings suggest that 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide could be developed into a novel anticancer drug.

In addition to its anti-inflammatory and antitumor properties, 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide has also been investigated for its antimicrobial activity. Studies have shown that this compound exhibits broad-spectrum antimicrobial effects against both Gram-positive and Gram-negative bacteria. The mechanism behind its antimicrobial activity is thought to involve the disruption of bacterial cell membranes, leading to cell death. This property makes it a potential candidate for the development of new antibiotics to combat multidrug-resistant bacterial infections.

The pharmacokinetic properties of 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide have also been studied to assess its suitability as a therapeutic agent. Preliminary data indicate that this compound has favorable absorption, distribution, metabolism, and excretion (ADME) properties. It exhibits good oral bioavailability and a reasonable half-life, which are essential characteristics for a drug candidate. However, further optimization may be required to enhance its pharmacokinetic profile and reduce potential side effects.

To fully realize the therapeutic potential of 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide, ongoing research is focused on optimizing its chemical structure through medicinal chemistry approaches. Structure-activity relationship (SAR) studies are being conducted to identify key functional groups that contribute to its biological activities and to develop more potent and selective analogs. Additionally, efforts are being made to improve its solubility and stability, which are critical factors for drug formulation and delivery.

In conclusion, 5-Methyl-1-p-tolyl-1h-pyrazole-4-carbohydrazide (CAS No. 618092-44-7) is a promising compound with diverse biological activities, including anti-inflammatory, antitumor, and antimicrobial properties. Its favorable pharmacokinetic profile and structural versatility make it an attractive scaffold for drug development. Ongoing research aims to further optimize this compound and explore its potential applications in various therapeutic areas.

• 98533-25-6(N,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXAMIDE)
• 175137-32-3(1-Phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carbohydrazide)
• 618092-46-9(1-(4-Methoxyphenyl)-5-methyl-1H-pyrazole-4-carbohydrazide)
• 204260-39-9(5-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOHYDRAZIDE)
• 618092-42-5(1-(4-Chlorophenyl)-5-methyl-1H-pyrazole-4-carbohydrazide)
• 618092-50-5(1-(4-Bromophenyl)-5-methyl-1H-pyrazole-4-carbohydrazide)
• 618092-48-1(1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carbohydrazide)
• 917947-72-9(1H-Pyrazole-4-carboxylic acid, 1,3-diphenyl-, 2-acetylhydrazide)
• 292852-03-0(1-PHENYL-5-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE)
• 618092-54-9(5-Methyl-1-O-tolyl-1H-pyrazole-4-carbohydrazide)